Guillaume Foillard
Private Equity Investor chez Turenne Capital Partenaires SA
Provenance du réseau au premier degré de Guillaume Foillard
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Turenne Capital Partenaires SA
 Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital Partenaires SA (Turenne Capital) is a venture capital subsidiary of Turenne Associés SA founded in 1999 by Aymard de Lasteyrie. The firm is headquartered in Paris, France.
43
| Subsidiary | Investment Managers | 43 |
LFPI Gestion SAS
 LFPI Gestion SAS Investment ManagersFinance LFPI Gestion SAS is a Private Equity firm, a subsidiary of La Financière Patrimoniale d'Investissement SAS founded in 2003. LFPI Gestion SAS is headquartered in Paris.
11
| Subsidiary | Investment Managers | 11 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Guillaume Foillard via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ALTRAN TECHNOLOGIES | Miscellaneous Commercial Services | Corporate Officer/Principal | |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Pharmaceuticals: Major | Director/Board Member | |
| TIGENIX NV | Medical Specialties | Director/Board Member | |
| KIORA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| EUROGERM SA | Food: Specialty/Candy | Director/Board Member | |
Innovacom Gestion SAS
 Innovacom Gestion SAS Investment ManagersFinance Innovacom Gestion SAS (Innovacom) is a venture capital firm founded in 1988 and a subsidiary of Turenne Capital Partenaires. Innovacom is headquartered in Paris, France with additional offices in Stockholm and San Francisco. | Investment Managers | Private Equity Analyst | |
| VALEO | Auto Parts: OEM | Chief Tech/Sci/R&D Officer | |
Sofimac Innovation SAS
 Sofimac Innovation SAS Investment ManagersFinance Sofimac Innovation SAS is an independent, early-stage venture capital firm which was created in 1998 by Eric Harlé and Didier Moret. Headquartered in Paris, France, Sofimac Innovation manages venture capital funds which provide equity financing for start-ups and early-stage companies in the Information and Communication Technologies (Software, SaaS, Multimedia and Telecom) sector. | Investment Managers | Private Equity Investor Private Equity Investor | |
Ventech SA
 Ventech SA Investment ManagersFinance Ventech SA is part of the venture capital arm and a wholly-owned subsidiary of Natixis Private Equity (NPE), which in turn is a subsidiary of Paris-based Natixis SA (XP: KN). Ventech was established in 1998 and is located in Paris. The firm specializes in technology venture capital investing. Ventech manages venture capital funds for a clientele of European institutional investors, with NPE as their sponsor. The firm relies on international strategic alliances with seeding funds and venture capital firms in Germany, Switzerland, Israel, Japan and the US. | Investment Managers | Private Equity Investor | |
| SCYNEXIS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Naxicap Partners SA
 Naxicap Partners SA Investment ManagersFinance Naxicap Partners SA operates as a private equity firm. It invests in hospitals, pharmaceuticals, business services, information technology, textile, and consumer goods sectors. The company was founded in 1995 and is headquartered in Paris, France. | Investment Managers | Chief Investment Officer Private Equity Analyst | |
Paluel-Marmont Capital SA
 Paluel-Marmont Capital SA Investment ManagersFinance Paluel-Marmont Capital SA (PMC) is the wholly-owned private equity subsidiary of Compagnie Lebon (XP: LBON) in France. Formerly known as Lebon Développement, the firm was established in 1991. Located in Paris, PMC invests their own equity in leveraged buy-outs in small- and mid-size businesses, sharing their professional expertise and business network with investee company management. | Investment Managers | Director/Board Member | |
Bertin Technologies SAS
 Bertin Technologies SAS Electronic Equipment/InstrumentsElectronic Technology Bertin Technologies SAS provides technical assistance and consulting services. It engages in developing and advising customers on electronic, optical, telecom, energy, biotech, and mechanical systems. The firm serves in the fields of energy, environment, life sciences, defense, and aerospace sectors. The company was founded in 1956 and is headquartered in Montigny-Le-Bretonneux, France. | Electronic Equipment/Instruments | Director/Board Member | |
XAnge Private Equity SA
 XAnge Private Equity SA Investment ManagersFinance XAnge Private Equity SA (XAnge Private Equity) is a private equity portfolio management firm which was created in 2003 by La Poste and ABN AMRO and is headquartered in France. | Investment Managers | Private Equity Investor | |
| National Aeronautics & Space Administration | General Government | Corporate Officer/Principal | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Graduate Degree Masters Business Admin | |
Institut National de la Santé & de la Recherche Médicale
 Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Director/Board Member | |
| Université Paris Dauphine-PSL | College/University | Graduate Degree Undergraduate Degree | |
| École Centrale Paris | College/University | Undergraduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Undergraduate Degree | |
| Institut d'Optique Graduate School | College/University | Undergraduate Degree | |
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member | |
| ALTUR INVESTISSEMENT | Investment Managers | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Investment Officer | |
A Plus Finance SA
 A Plus Finance SA Investment ManagersFinance A Plus Finance SA (A Plus Finance) is a private equity firm. The firm is founded in 1998 by Niels Court Payen andFrédéric Bayol. The firm headquartered in Paris, France. | Investment Managers | Private Equity Analyst | |
Siparex XAnge Venture SAS
 Siparex XAnge Venture SAS Investment ManagersFinance Siparex XAnge Venture SAS is an Independent Venture Capital firm founded in 1977 by Benjamin Teszner. Siparex XAnge Venture SAS is headquartered in Paris. | Investment Managers | Director/Board Member Private Equity Analyst | |
M Capital Partners SASU
 M Capital Partners SASU Investment ManagersFinance M Capital Partners SASU is an Independent Private Equity firm founded in 2001 by Rudy Secco. M Capital Partners SASU is headquartered in Toulouse. | Investment Managers | Private Equity Investor | |
Cellerix SA
 Cellerix SA Pharmaceuticals: GenericHealth Technology Founded in 2004, Cellerix is a biopharmaceutical company that develops innovative treatments based on cell therapy. Cellerix was founded within the Genetrix Group, group of biotechnology companies specialising in biomedicine. The Genetrix Group began its activities in 2001 at the National Centre for Biotechnology (CNB), which belongs to the Spanish Research Council (CSIC). One of the main objectives of Genetrix is to convert basic research results into therapeutic realities. Cellerix is leading the development of a new generation of medicines using expanded adult stem cells from adipose tissue (eASCs). Development is at a clinically advanced stage and the results from clinical trials in Phase I and II have been very promising. Obtaining these eASCs has big advantages because the process makes use of tissue that is almost always discarded from surgical procedures such as liposuction. eASCs have the capacity to activate physiological repair mechanisms through interaction with affected tissue. This technology represents a revolution in the treatment of some diseases that cannot satisfactorily be cured at present. Cellerix is working actively to adapt this new therapeutic strategy to treat autoimmune diseases such as inflammatory bowel disease. The main goal of the company is to market new tools for treating these diseases, which have a considerable negative impact of the quality of life of the sufferers. Cellerix also researches and develops medicines in other areas such as the development of skin equivalents, which are initially intended for the treatment of hereditary diseases such as epidermolysis bullosa. | Pharmaceuticals: Generic | Director/Board Member | |
Audacia PE
 Audacia PE Investment ManagersFinance Audacia PE is a Private Equity firm, a subsidiary of Audacia SA founded in 2006 by Charles Beigbeder and Alexis Dyèvre. Audacia PE is headquartered in Paris. | Investment Managers | Private Equity Investor | |
Covagen AG
 Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland. | Biotechnology | Director/Board Member | |
MW Gestion SA
 MW Gestion SA Investment ManagersFinance MW Gestion SA is an independent financial asset management firm headquartered in Paris, France. The firm was founded in 1992 and offers UCITS funds and discretionary mandates, specialized in share and bond investments to individuals and institutional clients. | Investment Managers | Director/Board Member | |
| Renaissance Corporate SAS | Investment Managers | President President | |
Millendo Therapeutics SAS
 Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France. | Medical Specialties | Director/Board Member | |
| Nord Capital Partenaires SAS | Investment Managers | Chief Executive Officer Chief Executive Officer Director/Board Member Private Equity Investor | |
| NOTE INC. | Internet Software/Services | Director/Board Member | |
Extens SAS
 Extens SAS Investment ManagersFinance Extens SAS (Extens) is an independent venture capital firm headquartered in Paris, France. The firm was founded by Arnaud Houette and Quentin Jacomet in 2013. | Investment Managers | Private Equity Investor | |
| L3S Partnership | Corporate Officer/Principal | ||
Essling Capital SAS
 Essling Capital SAS Investment ManagersFinance Essling Capital SAS (Essling Capital) is an independent private equity firm founded in 2016 by Frank-Noël Vandenberghe. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor Private Equity Analyst Private Equity Investor | |
Geneo Capital Entrepreneur SA
 Geneo Capital Entrepreneur SA Investment ManagersFinance Geneo Capital Entrepreneur SA is an Independent Private Equity/Venture Capital firm founded in 2018 by Fanny Letier. Geneo Capital Entrepreneur SA is headquartered in Neuilly-sur-Seine. | Investment Managers | Private Equity Investor | |
Jeito Capital SASU
 Jeito Capital SASU Investment ManagersFinance Jeito Capital SASU (Jeito Capital) is an Independent Venture Capital firm founded in 2018 by Rafaele Tordjman and headquartered in Paris, France. | Investment Managers | Private Equity Investor |
Statistiques
Internationale
| France | 37 |
| Etats-Unis | 6 |
| Belgique | 3 |
| Royaume-Uni | 3 |
| Espagne | 2 |
Sectorielle
| Finance | 21 |
| Health Technology | 14 |
| Consumer Services | 7 |
| Commercial Services | 4 |
| Consumer Non-Durables | 2 |
Opérationnelle
| Director/Board Member | 67 |
| Private Equity Investor | 60 |
| Private Equity Analyst | 27 |
| Corporate Officer/Principal | 22 |
| Chairman | 14 |
Relations les plus connectées
| Insiders | |
|---|---|
| Mounia Chaoui-Roulleau | 27 |
| François Lombard | 19 |
| Christian Maugey | 14 |
| Olivier Motte | 14 |
| Julie Rachline | 13 |
| Benoît Pastour | 10 |
| Hubert Michalowski | 8 |
| François Picarle | 8 |
| Antoine Fine | 6 |
| Marie Desportes | 6 |
| Fabien Bismuth | 5 |
| Anne-Sophie Maes | 4 |
| Marine Bussienne | 4 |
| Bervin Bouani | 4 |
| Stéphane Saudo | 3 |
- Bourse
- Insiders
- Guillaume Foillard
- Connexions Sociétés
